Top Markets
Coin of the day
Medtronic plc Medtronic plc

Medtronic plc

2M6
Rank in Stocks #164
Medtronic plc develops, manufactures, and sells device-based medical therapies... Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Share Price
$88.89
Market Cap
$114.13B
Change (1 day)
-0.93%
Change (1 year)
-2.08%
Country
IE
Trade Medtronic plc (2M6)

Category

Operating Margin for Medtronic plc (2M6)
Operating Margin as of March 2026 TTM: 17.86%
According to Medtronic plc latest financial reports and stock price the company's current Operating Margin (TTM) is 17.86%. At the end of 2024 the company had an Operating Margin of 15.89%.
Operating Margin history for Medtronic plc from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 17.86% 0.56%
2025 17.76% 11.77%
2024 15.89% -9.51%
2023 17.56% -3.25%
2022 18.15% 21.89%
2021 14.89% -10.14%
2020 16.57% -19.21%
2019 20.51% -7.49%
2018 22.17% 22.35%
2017 18.12% -2.53%
2016 18.59% 0.00%
2015 18.59% -17.08%
2014 22.42% -15.49%
2013 26.53% -4.22%
2012 27.70% -1.04%
2011 27.99% -7.50%
2010 30.26% 27.52%
2009 23.73% -12.14%
2008 27.01% -11.15%
2007 30.40% -7.35%
2006 32.81% -4.20%
2005 34.25% -2.17%
2004 35.01% 1.13%
2003 34.62% 3.28%
2002 33.52% -0.92%
2001 33.83% 0.77%
2000 33.57% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
18.16% -98.98%
US
22.44% -98.74%
US
17.86% -99.00%
IE
19.78% -98.89%
US
14.72% -99.18%
DE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.